Thoughts About Today. Firstly, it was encouraging to see that shareholders stood firm today. Less than 5M shares traded, on a base of 140M, and on a milestone day for the Company, shows that longs still dominate.
I hope that the Company is taking all steps necessary to avoid a recurrence of the "number of procedural issues" in future tests. Dr. Sokoll could only speak of " trends" and "potential" because of these errors. I am glad to see the plan to repeat the tests at an independent lab, to get the statsig dataToday was undoubtedly a setback, but not a showstopper. Let's take the time and effort to overcome the errors. Nothing today diminished the efficacy of the product.